Zoetis Acquired VitalRads. Here’s What That Means For Your Practice

One of the largest animal health companies in the world just doubled down on teleradiology. That’s not a small move. Here’s why it matters.Zoetis announced this week that it’s acquiring VitalRADS, a veterinary teleradiology platform that’s been quietly revolutionizing how practices access diagnostic imaging. This isn’t Zoetis buying a small startup to bury it. This is Zoetis making a strategic bet that the future of veterinary diagnostics looks like 24/7 access to board-certified specialists, AI-assisted report generation, and integrated cloud platforms. Translation: the way we do diagnostics is about to change. And if you’re running a practice, you should probably understand what that looks like.

What is VitaRads?

VitalRADS is a teleradiology service. You take a radiograph. You upload it. Within hours (or two hours for STAT cases), a board-certified veterinary radiologist reviews it and sends back a report. No travel. No referrals. No waiting for a specialist appointment that might be weeks out.

The platform serves more than 1,800 active customers across independent practices, corporate clinics, and university teaching hospitals. It’s not niche. It’s mainstream veterinary infrastructure that’s become essential to how many practices operate.

But VitalRADS doesn’t just do radiology. They also offer mobile ultrasound services in Houston and Seattle (performing scans on-site with portable equipment), an outpatient imaging center in Cypress, Texas, and VitalPACS—a cloud-based image storage system that integrates directly with your medical records.

That’s the full ecosystem. Not just “get a reading” but “manage your entire imaging workflow.”

Why did Zoetis buy it?

Zoetis is the world’s largest animal health company. They sell pharmaceuticals, vaccines, diagnostics, and digital solutions to practices globally. They’ve been building what they call a “Virtual Reference Laboratory”—basically an integrated system where you can run point-of-care tests (like their Vetscan platform), get same-day specialist interpretation, and have everything documented in one place.By acquiring VitalRADS, Zoetis is solving a major gap: radiology. They had in-clinic testing. They had reference lab capabilities. But they didn’t have direct access to specialist radiologists. Now they do. Twenty-four hours a day. Board-certified. AI-assisted.

Jamie Brannan, Zoetis’ Chief Commercial Officer, said it clearly: “By strengthening our diagnostics ecosystem beyond in-vitro testing and building a more complete end-to-end Virtual Lab offering for our customers, we’re advancing our strategic pursuit of opportunities that unlock new sources of growth.”

Translation: this is about making Zoetis indispensable. If you use Zoetis diagnostic equipment, Zoetis pharmaceuticals, and now Zoetis specialist radiologists, you’re building your entire practice around one company’s ecosystem. That’s a strategic move.

What this means for veterinarians

Short term: not much changes immediately. VitalRADS is staying VitalRADS. The service remains the same. Dr. Brian Poteet, VitalRADS’ founder and CEO, said in a statement that they’re “committed to delivering the high-quality service and support our clients rely on.”

But there’s a “but” here. Medium term: VitalRADS is going to integrate deeper into Zoetis’ ecosystem. The AI-assisted report generation that Zoetis mentioned? That’s going to get better. The integration with practice management software? That’s going to expand. The pricing? That might change, but we don’t know yet.Long term: Zoetis is building an end-to-end diagnostic platform where everything talks to everything else. Your point-of-care tests. Your reference lab results. Your specialist radiologist reports. Your image storage. All integrated. All streamlined. That’s genuinely useful if you’re in a Zoetis ecosystem. But it also means less independence. It means your diagnostics workflow becomes increasingly dependent on one company’s platforms and one company’s pricing decisions.

The AI Angle is Important

Here’s what actually matters from a technology perspective: VitalRADS uses AI to help generate draft radiology reports. The system looks at the images, pulls findings from the radiologist’s dictation, and creates a structured report. It flags areas where the AI interpretation and the radiologist’s findings diverge. This catches errors and speeds up the process.

This is real innovation. Reports that used to take hours to generate can be generated in minutes. Quality is actually improved because the AI is watching for inconsistencies. Radiologists can see more cases because they’re not spending as much time on administrative work.

But here’s the thing that nobody talks about: this technology is only as good as the data it’s trained on. And Zoetis is building a massive dataset by acquiring VitalRADS. Thousands of radiographs. Thousands of radiologist interpretations. Years of data that’s going to train Zoetis’ AI.

That’s valuable. And it’s also something worth thinking about if you’re concerned about where your diagnostic data is going and how it’s being used.

The Bigger Picture

This acquisition is part of a larger trend in veterinary medicine: consolidation. Corporate practices are consolidating independent practices. Pharmaceutical companies are consolidating diagnostic platforms. Equipment manufacturers are trying to own the entire workflow. Zoetis isn’t evil. They make good products. VitalRADS is genuinely useful. But this move is about control. It’s about making Zoetis such an integral part of how veterinarians work that alternatives become less competitive. If you’re an independent practice using VitalRADS, you’re now part of a Zoetis ecosystem. If you’re a corporate practice using Zoetis equipment and drugs, VitalRADS just became the obvious choice for your radiology. If you’re building a new practice, using Zoetis’ full suite of products starts to make economic sense.

That’s how consolidation happens. Not overnight. Not maliciously. Just step by step, product by product, until you realize you’re locked into one company’s vision of how veterinary medicine should work.

WHAT VITALRADS BRINGS TO ZOETIS

Let’s be clear about what Zoetis is getting:

•          1,800+ active customers (practices and universities)

•          24/7 access to board-certified specialists (radiologists, cardiologists, neurologists, dentists)

•          Mobile ultrasound service in two major markets

•          A PACS platform (image storage and management)

•          An American College of Veterinary Radiology certified residency program

•          Years of diagnostic imaging data

•          An established workflow that works

This is a fully operational business that’s been proving the concept for years. Zoetis isn’t betting on radiology being useful. They’re betting on being able to own the entire radiology workflow.

This is how modern veterinary medicine works now. Large companies buy innovative smaller companies. They integrate them. They build ecosystems. They make themselves indispensable. VitalRADS is genuinely good at what it does. Zoetis acquiring it and making it better is probably good for practices that use it. But it’s also worth understanding that this move is about control. It’s about Zoetis reducing the fragmentation in how practices do diagnostics and making Zoetis the answer to more and more of your practice’s needs. That’s not wrong. It’s just how corporate strategy works. But it’s worth having eyes open about it. Zoetis’ acquisition of VitalRADS is expected to close in Q3 2026. For more information about VitalRADS’ services, visit vitalrads.com. For questions about how this affects your practice’s workflow, reach out to your Zoetis representative or your current VitalRADS point of contact.